Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Downregulation of zinc finger protein 132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosis

28 Mar 2011

Abstract excerpt

This study investigates the expression and biomarker potential of zinc finger protein 132 (ZNF132) in prostate cancer (PC) by transcriptional profiling and immunohistochemical analysis of tissue microarrays, including tumor specimens from 615 radical prostatectomy (RP) patients and 199 conservatively treated patients. Primary clinical endpoints were time to PSA recurrence and cancer-specific death, respectively....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Epigenetics and DNA Methylation
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21445975
DOI: 10.1002/ijc.26097

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Downregulation of zinc finger protein 132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosisPMID 21445975Read ↗

ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancerSemantic proximity Read ↗

Downregulated ZNF132 Predicts Unfavorable Outcomes in Breast Cancer via Hypermethylation ModificationSemantic proximity Read ↗

DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of 'pan-negative'-type lung adenocarcinomas.Semantic proximity Read ↗

Pan-Cancer Analysis of Tumor Suppressor ZNF132 Reveals Its Diagnostic and Prognostic Significance with Immunomodulatory Implications in Colorectal CancerSemantic proximity Read ↗

Biomarker potential of ST 6 GALNAC 3 and ZNF 660 promoter hypermethylation in prostate cancer tissue and liquid biopsiesSemantic proximity Read ↗

Study of the Role of E2F1 and TMEM132A in Prostate Cancer DevelopmentSemantic proximity Read ↗

Deciphering the role of zinc homeostasis in the tumor microenvironment and prognosis of prostate cancerSemantic proximity Read ↗

Random forest-based modelling to detect biomarkers for prostate cancer progressionSemantic proximity Read ↗

IDH1R132H Promotes Malignant Transformation of Benign Prostatic Epithelium by Dysregulating MicroRNAs: Involvement of IGF1R-AKT/STAT3 Signaling Pathway.Semantic proximity Read ↗

CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patientsSemantic proximity Read ↗

Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancerSemantic proximity Read ↗

Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and PrognosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.